bg
A

Adaptimmune - ADR (ADAP)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Adaptimmune - ADR (ADAP)

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more

  • USD0.47
  • USD0.48
  • USD0.42
  • USD2.38
  • -13.60%
  • 58M
  • 363.32k
  • 429.42k
  • 106M
  • 0.42
  • -78.40%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.